Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Tax Provisions (2016 - 2025)

Avanos Medical's Tax Provisions history spans 11 years, with the latest figure at $3.6 million for Q3 2024.

  • For Q3 2024, Tax Provisions fell 41.94% year-over-year to $3.6 million; the TTM value through Sep 2024 reached $4.4 million, down 49.43%, while the annual FY2023 figure was $2.0 million, 61.54% down from the prior year.
  • Tax Provisions for Q3 2024 was $3.6 million at Avanos Medical, up from $1.9 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $37.9 million in Q3 2021 and bottomed at -$46.0 million in Q2 2021.
  • The 5-year median for Tax Provisions is -$800000.0 (2020), against an average of -$1.7 million.
  • The largest YoY upside for Tax Provisions was 425.0% in 2021 against a maximum downside of 1486.21% in 2021.
  • A 5-year view of Tax Provisions shows it stood at -$800000.0 in 2020, then skyrocketed by 425.0% to $2.6 million in 2021, then surged by 76.92% to $4.6 million in 2022, then tumbled by 145.65% to -$2.1 million in 2023, then soared by 271.43% to $3.6 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Tax Provisions are $3.6 million (Q3 2024), $1.9 million (Q2 2024), and $1.0 million (Q1 2024).